Perpetua Medical AB (publ) (STO:PERP.B)
Sweden · Delayed Price · Currency is SEK 2.750
-0.090 (-3.17%)
Sep 4, 2026, 2:22 PM CET
Perpetua Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 19.58 | 14.56 | 6.94 | 9.94 | 10.11 | 8.82 | |
Revenue Growth | 86.87% | 109.83% | -30.16% | -1.76% | 14.73% | 363.72% |
Cost of Revenue | 10.04 | 6.96 | 3.8 | 4.09 | 3.47 | 2.89 |
Gross Profit | 9.53 | 7.6 | 3.14 | 5.85 | 6.65 | 5.93 |
Selling, General & Admin | 21.38 | 14.89 | 10.94 | 23.78 | 25.56 | 19.37 |
Other Operating Expenses | -13.77 | -11.83 | -5.66 | 0.38 | -0.19 | -0.14 |
Operating Expenses | 11.89 | 5.56 | 5.6 | 24.34 | 25.76 | 19.61 |
Operating Income | -2.36 | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 |
Interest Expense | -0.78 | -0.7 | -0.08 | -0.07 | -0.13 | -0.15 |
Interest & Investment Income | 0.31 | 0.08 | 0.29 | 0.29 | 0.07 | 0.12 |
Other Non Operating Income (Expenses) | -0 | 0 | - | - | -0 | - |
EBT Excluding Unusual Items | -2.84 | 1.42 | -2.24 | -18.28 | -19.16 | -13.71 |
Gain (Loss) on Sale of Assets | -0.23 | -0.23 | 0.04 | - | - | - |
Pretax Income | -3.07 | 1.19 | -2.2 | -18.28 | -19.16 | -13.71 |
Income Tax Expense | -0.39 | -0.02 | 0.18 | - | - | - |
Earnings From Continuing Operations | -2.67 | 1.22 | -2.38 | -18.28 | -19.16 | -13.71 |
Minority Interest in Earnings | 3.01 | 1.24 | -0.09 | - | - | - |
Net Income | 0.34 | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 |
Net Income to Common | 0.34 | 2.45 | -2.47 | -18.28 | -19.16 | -13.71 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 7 | 5 | 4 | 2 | 1 | 1 |
Shares Outstanding (Diluted) | 7 | 5 | 4 | 2 | 1 | 1 |
Shares Change | 47.32% | 9.65% | 145.32% | 153.20% | 20.61% | 20.91% |
EPS (Basic) | 0.05 | 0.53 | -0.58 | -10.56 | -28.03 | -24.18 |
EPS (Diluted) | 0.05 | 0.53 | -0.58 | -10.56 | -28.03 | -24.18 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -7.38 | -6.53 | -7.03 | -16.41 | -19.65 | -15.84 |
Free Cash Flow Per Share | -1.11 | -1.40 | -1.66 | -9.48 | -28.74 | -27.94 |
Gross Margin | 48.69% | 52.21% | 45.27% | 58.85% | 65.72% | 67.26% |
Operating Margin | -12.07% | 14.04% | -35.39% | -186.11% | -188.94% | -155.22% |
Profit Margin | 1.73% | 16.84% | -35.64% | -183.94% | -189.48% | -155.54% |
Free Cash Flow Margin | -37.68% | -44.87% | -101.27% | -165.16% | -194.31% | -179.68% |
EBITDA | 1.93 | 4.54 | -2.13 | -18.31 | -18.72 | -13.3 |
EBITDA Margin | 9.85% | 31.21% | -30.73% | -184.31% | -185.10% | -150.87% |
D&A For EBITDA | 4.29 | 2.5 | 0.32 | 0.18 | 0.39 | 0.38 |
EBIT | -2.36 | 2.04 | -2.46 | -18.49 | -19.11 | -13.68 |
EBIT Margin | -12.07% | 14.04% | -35.39% | -186.11% | -188.94% | -155.22% |
Revenue as Reported | 33.5 | 26.51 | 14.15 | 9.98 | 10.42 | 9 |